COPD
Conditions
Interventions
None listed
Sponsors
AstraZeneca.KK
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who have provided written informed consent for participation in this study 2)Male and female patients aged at least 40 years at the time of enrolment who are given diagnosis of COPD by a physician 3)Patients whose respiratory function test values after bronchodilators (FEV1, FVC, IC) are available 4)Patients whose DLCO values and data on the presence/absence of emphysema by a chest CT scan are available 5)Outpatients who are able to answer the questionnaires and start measurement with an activity meter within four weeks after informed consent and measure activities for 14 consecutive days
Exclusion criteria
Exclusion criteria: 1)Patients who have participated in any other interventional studies such as clinical trials within the past eight weeks 2)Patients determined to be inappropriate to be enrolled in this study by investigators because they cannot comply with the procedures, limitations, and requirements of this study, or for other reasons. 3)Patients with an exacerbation of COPDa within the past eight weeks 4)Patients who require home oxygen therapy (excluding those who use it only during nighttime)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Daily step counts of patients with COPD 2)Activity time of each activity intensity (METs) in patients with COPD 3)Correlation between levels of physical activity and demographic factors in patients with COPD | — |
Countries
Japan
Contacts
Public ContactTatsunori Jinnai
AstraZeneca.KK Medical, Evidence & Observational Research
Outcome results
None listed